Tempus is an industry leader analyzing clinical and molecular data to identify actionable clinical trial options for cancer patients. Through our proprietary trial matching software and methods, we identify relevant, open, and recruiting clinical trials personalized to each patient’s molecular and clinical context.
THE TIME TRIAL® NETWORK
Accessing the right clinical trial for the right patient at the right time
The TIME Trial Program is a just-in-time network of providers to support rapid patient identification, site activation, and enrollment of select clinical trials. Through the TIME Trial Program, 2,600 oncologists and their patients have unprecedented access to a large portfolio of cutting-edge precision medicine trials.
“Tempus provides an unparalleled level of commitment and support in aligning all involved parties and streamlining the process, especially given the challenges of the COVID-19 pandemic. We ultimately met our target goal of activating our trial in just two weeks”
Dr. Julio Peguero,
Director of Research, Oncology Consultants
Precision medicine has changed the clinical research landscape
30+ unique clinical trials targeting a wide array of biomarkers including FGFR, KEAP1, RET, NOTCH1, ESR1, and MET.
Smart trial matching Each patient’s sequenced molecular data and clinical history are compared against each trial’s structured inclusion and exclusion criteria through our proprietary trial matching software and methods.
Rapid site activation Tempus utilizes a standardized contract, rate card, feasibility process, informed consent form (ICF), and a central IRB along with a team of dedicated research liaisons to streamline activities for study start-up.
Site activated in an average of 10 days.
Trial Matching at Tempus
Tempus patients match
to a biomarker trial
TRIAL MATCHING ALGORITHM
A new precision medicine approach to clinical trials
Tempus generates, organizes, and analyzes extensive amounts of data through our next-generation sequencing lab, AI-assisted clinical data structuring capabilities, and connectivity with researchers across the network. We support providers in identifying relevant and actionable clinical trials for their patients.
Our proprietary clinical trial matching software enables real-time matches for relevant, open, and recruiting clinical trials. Tempus’ team of trained abstractors manually reviews all protocol-specific inclusion and exclusion eligibility criteria for trials in the TIME Trial Program.
Bringing the right clinical trial to the right patient in days instead of months
The program is designed to provide access to thousands of physicians and patients to clinical trials and novel therapeutics, no matter where they are.
All sites and sponsors participating in the TIME Trial Program commit to a standard clinical trial agreement, a pre-negotiated budget, and the use of a central IRB. Additionally, Tempus’ dedicated, expert research liaisons support sites and sponsors in streamlining all recruitment and enrollment activities
The entire activation process is designed to take 10 business days, and the site always makes the decision about particular studies for involvement.
“The current clinical trial process is cumbersome and inefficient. As treatments become more molecularly targeted, finding innovative ways to increase participation is key to therapeutic development and ultimately improved patient care. Having a TIME Trial model is visionary and the wave of the future. This model has the potential to bring innovative and novel therapies to a larger percentage of our patients.”
Dr. Michael P. Kosty,
MD, FACP, FASCO, Director of Thoracic Oncology, Scripps/MD Anderson Cancer Center in La Jolla, CA.
TIME TECH SPOTLIGHT
The TIME Trial Program activates unique clinical trials targeting a range of biomarkers at Institutions across the United States.
Learn more about recent rapid activation success stories in our TIME Tech Spotlight.